pharmaphorum

JULY 14, 2022

A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors. It may also help the regulator to define target treatment populations better.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52

pharmaphorum

JANUARY 24, 2022

Protas will design and run smart clinical trials through collaborations with charities, foundations, academic research teams and industry partners, and will take on both repurposed and experimental drugs. “It’s not about making money from the trials, it’s about driving public health benefit,” he told the BBC.

Trials 90

Trials Drugs Clinical Trials Clinical Trials 90

pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. Hybrid or decentralised clinical trials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. Novel digital endpoints.

Clinical Trials 85

Clinical Trials Clinical Trials Trials Regulation 85

pharmaphorum

JUNE 8, 2021

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market. At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home. About the interviewee.

Marketing 104

Marketing Drugs Regulation Development 104

Drug Discovery World

SEPTEMBER 28, 2022

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. AI algorithms are able to quickly analyse and spot patterns in vast swathes of data.

Pharma Companies 52

Pharma Companies Drugs In-Vivo Genetics 52

pharmaphorum

DECEMBER 16, 2020

Soon the ABPI and the entire industry were facing the ripple effects of COVID-19, including a significant slowdown in non-COVID clinical research, which Torbett says was challenging for the industry to deal with. “We’ve “It’s been a very interesting year to kick things off.”. A collaborative future. The road to a vaccine.

Vaccination 120

Vaccination Vaccine Life Science In-Vitro 120

pharmaphorum

DECEMBER 21, 2021

In a recent webinar held by pharmaphorum, in partnership with IQVIA, a discussion was held looking at how to make academic and commercial medical research more efficient, while also looking at the opportunity of genomic data to bring benefits to patients and healthcare systems. Headway being made.

Development 97

Development Genome Genomics Drugs 97

pharmaphorum

AUGUST 31, 2021

For the healthcare ecosystem to drive research and care, clarity is needed about the opportunities and challenges of ECAs and their value in bringing therapies to patients faster, say COTA Viraj Narayanan and Karla Feghali from ConvergeHEALTH by Deloitte. Myth 3: RWD is too imperfect to be used to as a comparator arm to a clinical trial.

Clinical Trials 72

Clinical Trials Clinical Trials Life Science Trials 72

Cloudbyz

MAY 19, 2021

billion in 2030 (Source: the business research compan y). Moreover, 12% of industrial clinical pipeline products and at least 16% of preclinical pipeline products consist of CGT. However, the major challenge is the newness and uncharted territory of the CGT field for service companies.

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

pharmaphorum

APRIL 7, 2021

While the Darzalex revenues are due to fall this year because of Janssen’s interpretation of the agreement between the two companies, there are also other revenue streams. With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies. Role models.

Antibody 71

Antibody Life Science Development Regulation 71

XTalks

MAY 6, 2022

Diane Lacroix is an accomplished data management professional and leader with a career of over 20 years in the pharmaceutical and contract research organization (CRO) industry. Therefore, a clinical data pipeline can help with incorporating, organizing, mapping and analyzing data to keep up with research data. In addition, 43.4

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

XTalks

MAY 11, 2023

Wendy: RARE-X is now the data and research arm of Global Genes, the flagship patient organization representing rare, ultra-rare, and “n-of-one” patients. Now it’s regulators, payers, academics, patient communities, physicians and industry all asking, “Where have you incorporated the patient voice? We know this works.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

The Pharma Data

DECEMBER 17, 2020

He previously spent more than a decade at Medtronic in the company ’ s Minimally Invasive Therapies Group where he served as the global vice president and General Manager of General Surgery, and in various roles working on research, development, and strategy. AB2 Bio – Swiss pharma company AB2 Bio Ltd.

Development 52

Development Gene Therapy Engineer Life Science 52

pharmaphorum

MARCH 12, 2021

Speakers at the NIHR’s recent virtual event for the pharma industry discussed best practices for bringing patient insights into research. They’re not having to travel to speak to researchers in person anymore,” he said. Likewise, we’ve got greater flexibility in being able to do research at a time of their choosing.

Trials 126

Trials Research Pharma Companies Clinical Trials 126

pharmaphorum

MAY 26, 2022

Inadequate clinical trial representations of all populations can therefore leave underrepresented groups vulnerable due to the lack of subgroup-specific data. While many pharma companies are actively working on initiatives to improve diversity in clinical trials, we still have a long way to go.

Clinical Trials 139

Clinical Trials Clinical Trials Trials Medicine 139

pharmaphorum

OCTOBER 18, 2021

There was a genuine sense of alliance; regulatory bodies and pharma companies coming together to accelerate processes and find the most optimal model for collaboration. What remains very clear is that collaboration between sponsor companies, health authorities and other stakeholders will be required to move this forward.

Vaccination 136

Vaccination Vaccine Regulation Medicine 136

pharmaphorum

NOVEMBER 3, 2022

Beyond digital clinical measures, digital solutions are maturing to address major challenges facing clinical research and offer enormous promise to support the key performance indicators (KPIs) for every member of our industry. Pharma companies with more mature digital strategies are able to focus on questions of scale.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Medicine 80

pharmaphorum

FEBRUARY 16, 2022

The two companies have collaborated to launch a new digital platform that promises to make clinical studies “more efficient, comprehensive and inclusive” – building in RWD from the ground up – and provide researchers “with a totality of evidence to inform their research,” according to Thread chief executive John Reites.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Pharma Companies 52

pharmaphorum

SEPTEMBER 1, 2020

The war had also encouraged research into everything from new analgesics to drugs against typhus, with a great deal of collaboration between the companies and government. ” This public-spirited industry still required greater oversight, however, and government regulations on medicines increased on both sides of the Atlantic.

Medicine 145

Medicine Insulin Pharmacy Drugs 145

pharmaphorum

DECEMBER 22, 2021

The ‘PEP Talks’ monthly e-newsletter has approaching 50 pharma companies as subscribers and the inaugural ‘Patient Engagement Day’ on September 01 st achieved an inspirational number of downloads of toolkits for ways to ‘Amplify the Patient Voice’ as the launch theme. Harmonising rare disease PAG insights.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Pharma Companies 100

XTalks

SEPTEMBER 5, 2023

Xtalks spoke with Maria Reyes Boceta-Muñoz, Clinical Operations Head of Development R&D at GlaxoSmithKline in Spain, Portugal & Israel, to understand the current vaccine development climate and where the sector is headed. What are the major challenges you’re facing right now in vaccine development?

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

pharmaphorum

DECEMBER 15, 2022

For health innovation, digital transformation in the NHS – using digital technology to change and improve services and outcomes for patients, including primary care records, legacy items, and clinical research – is critical. The UK as a powerhouse of research. So, too, is addressing digital health inequalities.

Life Science 92

Life Science Medicine Clinical Trials Clinical Trials 92

XTalks

OCTOBER 1, 2020

WeiQi Lin, MD, PhD, executive vice president of research & development and principal scientist, DURECT Corporation. Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading business development in industry. Motivations for Transition.

Scientist 52

Scientist In-Vitro Research Life Science 52

Pharmaceutical Technology

APRIL 12, 2023

Pharmaceutical research has long relied on non-human primate models for early-stage discoveries, but their use continues to cause controversy. Globally, non-human primates make up a relatively small percentage of the animals used in research. This was part of an investigation into an international primate smuggling ring.

Regulation 245

Regulation Vaccination Vaccine Medicine 245

pharmaphorum

NOVEMBER 15, 2021

.” After his 11-month stint heading the agency, Califf returned to his role as a cardiologist whilst also serving as a health policy and strategy advisor to Google’s unit life sciences unit Verily and running Duke University’s Clinical Research Institute, which he founded in 1996. ” he said in a statement.

Regulation 95

Regulation Life Science Pharma Companies Branding 95